Associate Professor, Radiation Oncology, Washington University in St. Louis School of Medicine
Radiation Oncology
Dr. Wade L. Thorstad, MD
|
|
Give Review
Doctor Wade L. Thorstad, MD works in the field of Radiation Oncology. He went to medical school at University of Arkansas for Medical Sciences. University of Arkansas for Medical Sciences is ranked 83/35 in Research/PrimaryCare. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Wade L. Thorstad is a published physician as well. He has 46 publications published. The latest was: Locally increased uptake of fluorine-18-fluorodeoxyglucose after intracavitary administration of iodine-131-labeled antibody for primary brain tumors. He accepts all Medicare patients.
Publications
- Definitive Surgical Therapy after Open Neck Biopsy for HPV-Related Oropharyngeal Cancer.
- High metastatic node number, not extracapsular spread or N-classification is a node-related prognosticator in transorally-resected, neck-dissected p16-positive orophar...
- Automated contouring error detection based on supervised geometric attribute distribution models for radiation therapy: a general strategy.
- Nab-paclitaxel-based compared to docetaxel-based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neck.
- PET-Based Radiation Therapy Planning.
- Looking beyond the CRT paradigm: Why induction chemotherapy is worthy of pursuit.
- Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522.
- Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life.
- Dermatofibrosarcoma protuberans, version 1.2014.
- Management of human papillomavirus-related unknown primaries of the head and neck with a transoral surgical approach.
- Keratinizing-Type Squamous Cell Carcinoma of the Oropharynx: p16 Overexpression Is Associated With Positive High-Risk HPV Status and Improved Survival.
- Multi-institutional Quantitative Evaluation and Clinical Validation of Smart Probabilistic Image Contouring Engine (SPICE) Autosegmentation of Target Structures and No...
- Extensive HPV-Related Carcinoma In Situ of the Upper Aerodigestive Tract with 'Nonkeratinizing' Histologic Features.
- A Quantitative Histomorphometric Classifier (QuHbIC) Identifies Aggressive Versus Indolent p16-Positive Oropharyngeal Squamous Cell Carcinoma.
- Cyclin D1-a prognostic marker in oropharyngeal squamous cell carcinoma that is tightly associated with high-risk human papillomavirus status.
- Prognostic value of (18)F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma.
- Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer.
- Detection and significance of human papillomavirus, CDKN2A(p16) and CDKN1A(p21) expression in squamous cell carcinoma of the larynx.
- A phase 2 trial of induction nab-paclitaxel and cetuximab given with cisplatin and 5-fluorouracil followed by concurrent cisplatin and radiation for locally advanced s...
- A novel RT-PCR method for quantification of human papillomavirus transcripts in archived tissues and its application in oropharyngeal cancer prognosis.
- A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinoma.
- Pretreatment nutritional status and locoregional failure of patients with head and neck cancer undergoing definitive concurrent chemoradiation therapy.
- High-Risk Human Papillomavirus E6/E7 mRNA Detection by a Novel In Situ Hybridization Assay Strongly Correlates With p16 Expression and Patient Outcomes in Oropharyngea...
- Extracapsular extension is a poor predictor of disease recurrence in surgically treated oropharyngeal squamous cell carcinoma.
- Human papillomavirus-related squamous cell carcinoma of the oropharynx: a comparative study in whites and African Americans.
- p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status.
- Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors.
- HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome.
- A novel PET tumor delineation method based on adaptive region-growing and dual-front active contours.
- Temporal relationship between antitumor necrosis factor-alpha antibody therapy and recrudescence of head and neck squamous cell carcinoma.
- A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma.
- Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
- Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
- Carcinoma of paranasal sinuses: long-term outcomes with radiotherapy.
- Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
- Pilot study of subcutaneous amifostine in patients undergoing postoperative intensity modulated radiation therapy for head and neck cancer: preliminary data.
- Role of fusion in radiotherapy treatment planning.
- Endovascular brachytherapy for treatment of bilateral renal artery in-stent restenosis.
- Cisplatin versus Cetuximab Given Concurrently with Definitive Radiation Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma.
- A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary anal...
- Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225.
- IMRT treatment planning based on prioritizing prescription goals.
- Regarding Zhang, Gu, Yin, IJROBP 1998;42:928-934.
- Locally increased uptake of fluorine-18-fluorodeoxyglucose after intracavitary administration of iodine-131-labeled antibody for primary brain tumors.
- Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results.
Schools
University Of Texas Medical School At Houston
Duke University Med Center
Loyola University Med Center
University Of Ar College Of Med
Doctors Specialties
- Nuclear Medicine
- Radiation Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Duke University Hospital -
Loyola University -
University of Arkansas for Medical Sciences -
University of Texas Medical School
Hospital
-
Barnes-Jewish Hospital -
St. Louis Children's Hospital
Drug Facts
| NPI NUMBER | 1356367668 | |
| NPPES Provider LastName | THORSTAD | |
| NPPES Provider FirstName | WADE | |
| NPPES Provider ZIPCode | 631101032 | |
| NPPES Provider State | MO | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 115.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 52.0 | |
| Percent Opioid Claims | 45.22 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1356367668 |
| Last Name Of The Provider | THORSTAD |
| First Name Of The Provider | WADE |
| View All |
Similar Doctors
|
|
Dr. Jaymeson S. Stroud, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Mackenzie D. Daly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth A. Kidd, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mustafa E. Altinyay, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amir G. Abdelmalik, MD |
|
|
Dr. James W. Debnam Jr., MD |
|
|
Dr. Farrokh Dehdashti, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Hiram A. Gay, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric J. Sutphen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph N. Fields III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fozia R. Qazi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey M. Craft, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew J. Hope, MD |
|
|
Dr. Razi Muzaffar, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sana Rehman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Houman Sotoudeh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert C. Frazier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie A. Mai, MD
This Doctor is OpenDoctor Recommended.
|